Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Total Non-Current Liabilities: 2024

Historic Total Non-Current Liabilities for Eton Pharmaceuticals (ETON) over the last 1 years, with Dec 2024 value amounting to $49.9 million.

  • Eton Pharmaceuticals' Total Non-Current Liabilities was N/A to $76.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.2 million, marking a year-over-year change of. This contributed to the annual value of $49.9 million for FY2024, which is N/A change from last year.
  • Eton Pharmaceuticals' Total Non-Current Liabilities amounted to $49.9 million in FY2024.
  • Eton Pharmaceuticals' Total Non-Current Liabilities' 5-year high stood at $49.9 million during FY2024, with a 5-year trough of $49.9 million in FY2024.
  • Over the past 1 years, Eton Pharmaceuticals' median Total Non-Current Liabilities value was $49.9 million (recorded in 2024), while the average stood at $49.9 million.